eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -37.21%64.5M | -20.74%27.68M | -21.09%26.64M | -55.85%12.75M | -149.43%-2.56M | 179.90%102.73M | 402.08%34.92M | 225.40%33.76M | 407.61%28.87M | -83.92%5.18M |
Net income from continuing operations | 13.94%27.91M | -230.39%-8.26M | 2,934.29%8.93M | -52.02%13.44M | 2,080.34%13.8M | 135.74%24.49M | 83.49%-2.5M | 96.61%-315K | 312.71%28M | 97.75%-697K |
Operating gains losses | -90.52%4.85M | -98.63%672K | 149.83%5.76M | -106.34%-419K | -116.82%-1.16M | 322.51%51.13M | 2,982.45%49.17M | -278.19%-11.55M | 344.72%6.61M | 2.74%6.91M |
Depreciation and amortization | 5.29%45.74M | 3.84%12.83M | 26.66%11.11M | -14.35%10.61M | 12.71%11.19M | 5.70%43.44M | 12.17%12.36M | -12.51%8.77M | 24.86%12.38M | -2.08%9.93M |
Deferred tax | 80.32%-2.78M | -28.46%842K | -142.33%-3.4M | 80.97%-3.08M | 139.77%2.86M | -218.05%-14.14M | -40.22%1.18M | 256.73%8.04M | -947.80%-16.18M | -143.03%-7.18M |
Other non cash items | -50.65%4.32M | -75.77%1.36M | -18.30%1.19M | 15.13%913K | -3.18%853K | 260.50%8.75M | 452.06%5.62M | 170.19%1.46M | 87.91%793K | 96.65%881K |
Change In working capital | -41.09%-39.83M | 127.91%10.5M | -108.82%-1.94M | -4,008.79%-9.34M | -205.22%-39.06M | -5,732.85%-28.23M | -95.33%-37.64M | 3,766.44%21.96M | -94.64%239K | -185.74%-12.8M |
-Change in receivables | -47.03%-126.12M | -4.90%-35.98M | -2,340.75%-29.8M | -10.21%-36.2M | -20.94%-24.13M | -396.98%-85.77M | -86.19%-34.3M | -84.55%1.33M | -7.41%-32.85M | -186.27%-19.96M |
-Change in payables and accrued expense | -12.34%104.7M | 414.86%46.69M | -28.63%33.68M | -57.60%21.31M | -76.62%3.02M | 1,573.97%119.44M | 37.37%9.07M | 481.78%47.18M | 152.08%50.25M | 283.61%12.93M |
-Change in other current assets | 46.64%-25.46M | 60.25%-18.04M | -3,983.67%-2M | 199.00%5.82M | -412.88%-11.25M | -270.01%-47.72M | -8,166.30%-45.38M | 99.85%-49K | -126.37%-5.88M | -90.89%3.6M |
-Change in other current liabilities | 78.79%-5.72M | -32.88%17.9M | 79.17%-5.73M | 62.38%-5.51M | -8.07%-12.37M | 3.50%-26.95M | 400.30%26.66M | -182.65%-27.51M | -58.95%-14.66M | 73.46%-11.45M |
-Change in other working capital | -0.04%12.77M | -101.08%-68K | 90.30%1.92M | 55.47%5.24M | 172.95%5.67M | 34.48%12.77M | 218.84%6.31M | -66.57%1.01M | 67.05%3.37M | -16.14%2.08M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -37.21%64.5M | -20.74%27.68M | -21.09%26.64M | -55.85%12.75M | -149.43%-2.56M | 179.90%102.73M | 402.08%34.92M | 225.40%33.76M | 407.61%28.87M | -83.92%5.18M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 31.09%-36.22M | 40.74%-7.68M | 47.94%-7.23M | 30.98%-11.5M | -8.40%-9.81M | -2.77%-52.56M | -50.24%-12.95M | 34.97%-13.9M | -66.35%-16.66M | 18.75%-9.05M |
Capital expenditure reported | 2.62%-30.33M | 0.46%-7.42M | -3.19%-7.73M | 14.74%-8.03M | -5.41%-7.15M | -18.10%-31.15M | ---7.45M | -7.62%-7.5M | ---9.41M | 4.40%-6.79M |
Net PPE purchase and sale | 33.93%-6.49M | 65.14%-1.3M | 43.19%-1.81M | -43.17%-2.19M | 13.91%-1.19M | -129.01%-9.82M | -597.19%-3.72M | -81.98%-3.18M | -61.12%-1.53M | -31.22%-1.39M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | 105.18%601K | 158.49%1.04M | 171.65%2.31M | 77.56%-1.28M | -66.82%-1.46M | 13.90%-11.59M | -147.38%-1.78M | 66.59%-3.22M | -24.44%-5.72M | 70.61%-877K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 31.09%-36.22M | 40.74%-7.68M | 47.94%-7.23M | 30.98%-11.5M | -8.40%-9.81M | -2.77%-52.56M | -50.24%-12.95M | 34.97%-13.9M | -66.35%-16.66M | 18.75%-9.05M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 86.62%-5.11M | 237.73%17.27M | -94.42%-4.42M | 259.58%2.57M | 5.78%-20.54M | -51.08%-38.22M | -178.67%-12.54M | -152.30%-2.28M | 29.01%-1.61M | 4.73%-21.8M |
Net issuance payments of debt | 188.86%18.2M | 263.69%17.26M | -32.48%3.1M | 359.26%2.51M | 65.58%-4.67M | -515.04%-20.48M | -859.04%-10.54M | -55.50%4.59M | -15.67%-967K | -128.70%-13.56M |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash dividends paid | -32.04%-23.44M | --0 | 10.04%-7.52M | --0 | -93.14%-15.92M | -2.16%-17.75M | 0.00%-504K | -942.27%-8.36M | -179.65%-646K | 47.97%-8.24M |
Proceeds from stock option exercised by employees | ---- | --13K | ---- | --67K | --46K | -98.82%4K | ---- | ---- | --0 | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 287.13%1.5M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 86.62%-5.11M | 237.73%17.27M | -94.42%-4.42M | 259.58%2.57M | 5.78%-20.54M | -51.08%-38.22M | -178.67%-12.54M | -152.30%-2.28M | 29.01%-1.61M | 4.73%-21.8M |
Net cash flow | ||||||||||
Beginning cash position | 2.34%250.79M | -14.09%219.68M | -16.17%204.48M | -6.54%213.11M | 2.34%250.79M | -12.24%245.05M | -2.80%255.71M | -11.22%243.93M | -20.21%228.02M | -12.24%245.05M |
Current changes in cash | 93.92%23.17M | 295.32%37.28M | -14.82%14.98M | -63.94%3.82M | -28.20%-32.91M | 130.06%11.95M | 138.20%9.43M | 364.73%17.59M | 260.63%10.6M | -1,311.83%-25.67M |
Effect of exchange rate changes | -330.99%-26.74M | 32.14%-9.74M | 103.68%214K | -334.36%-12.45M | -155.21%-4.77M | -211.52%-6.21M | -315.81%-14.35M | -15.29%-5.81M | 220.70%5.31M | 3.40%8.64M |
End cash Position | -1.42%247.22M | -1.42%247.22M | -14.09%219.68M | -16.17%204.48M | -6.54%213.11M | 2.34%250.79M | 2.34%250.79M | -2.80%255.71M | -11.22%243.93M | -20.21%228.02M |
Free cash flow | -55.18%27.68M | -20.14%18.96M | -25.93%17.1M | -85.88%2.53M | -264.30%-10.91M | 922.24%61.76M | 216.64%23.75M | 1,288.75%23.08M | 2,479.86%17.93M | -112.45%-2.99M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |